Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Eltrombopag> ?p ?o }
- Eltrombopag abstract "Eltrombopag (rINN, codenamed SB-497115-GR) is a medication that has been developed for conditions that lead to thrombocytopenia (abnormally low platelet counts). It is a small molecule agonist of the c-mpl (TpoR) receptor, which is the physiological target of the hormone thrombopoietin. Eltrombopag was discovered as a result of research collaboration between GlaxoSmithKline and Ligand Pharmaceuticals. Designated an orphan drug in the USA and European Union, it is being manufactured and marketed by GlaxoSmithKline under the trade name Promacta in the USA and is marketed as Revolade in the EU. Eltrombopag was approved by the U.S. Food and Drug Administration on November 20, 2008. Eltrombopag received FDA breakthrough treatment designation in February 2014 for patients with aplastic anemia for which immunosuppression has not been successful. It has been shown to produce a trilineage hematopoesis in some patients with aplastic anemia, resulting in increased platelet counts, along with red and white blood cell counts.".
- Eltrombopag atcPrefix "B02".
- Eltrombopag atcSuffix "BX05".
- Eltrombopag casNumber "496775-61-2".
- Eltrombopag casSupplemental "(olamine)".
- Eltrombopag fdaUniiCode "S56D65XJ9G".
- Eltrombopag iupacName "3'-{(2Z)-2-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene]hydrazino}-2'-hydroxy-3-biphenylcarboxylic acid".
- Eltrombopag pubchem "9846180".
- Eltrombopag thumbnail Eltrombopag.svg?width=300.
- Eltrombopag wikiPageID "14488084".
- Eltrombopag wikiPageLength "7739".
- Eltrombopag wikiPageOutDegree "33".
- Eltrombopag wikiPageRevisionID "693108846".
- Eltrombopag wikiPageWikiLink Agonist.
- Eltrombopag wikiPageWikiLink Aplastic_anemia.
- Eltrombopag wikiPageWikiLink CYP1A2.
- Eltrombopag wikiPageWikiLink CYP2C8.
- Eltrombopag wikiPageWikiLink Category:Biphenyls.
- Eltrombopag wikiPageWikiLink Category:Breakthrough_therapy.
- Eltrombopag wikiPageWikiLink Category:Carboxylic_acids.
- Eltrombopag wikiPageWikiLink Category:Drugs_acting_on_the_cardiovascular_system.
- Eltrombopag wikiPageWikiLink Category:Hydrazines.
- Eltrombopag wikiPageWikiLink Category:Orphan_drugs.
- Eltrombopag wikiPageWikiLink Cirrhosis.
- Eltrombopag wikiPageWikiLink Ethanolamine.
- Eltrombopag wikiPageWikiLink European_Union.
- Eltrombopag wikiPageWikiLink Food_and_Drug_Administration.
- Eltrombopag wikiPageWikiLink GlaxoSmithKline.
- Eltrombopag wikiPageWikiLink Hepatitis_C.
- Eltrombopag wikiPageWikiLink Hormone.
- Eltrombopag wikiPageWikiLink Immune_thrombocytopenic_purpura.
- Eltrombopag wikiPageWikiLink Interferon.
- Eltrombopag wikiPageWikiLink International_nonproprietary_name.
- Eltrombopag wikiPageWikiLink JAK-STAT_signaling_pathway.
- Eltrombopag wikiPageWikiLink Ligand_Pharmaceuticals.
- Eltrombopag wikiPageWikiLink Liver.
- Eltrombopag wikiPageWikiLink Megakaryocyte.
- Eltrombopag wikiPageWikiLink Orphan_drug.
- Eltrombopag wikiPageWikiLink Pharmaceutical_drug.
- Eltrombopag wikiPageWikiLink Platelet.
- Eltrombopag wikiPageWikiLink Receptor_(biochemistry).
- Eltrombopag wikiPageWikiLink Thrombocytopenia.
- Eltrombopag wikiPageWikiLink Thrombopoietin.
- Eltrombopag wikiPageWikiLink Thrombopoietin_receptor.
- Eltrombopag wikiPageWikiLink United_States.
- Eltrombopag wikiPageWikiLinkText "Eltrombopag".
- Eltrombopag wikiPageWikiLinkText "eltrombopag".
- Eltrombopag atcPrefix "B02".
- Eltrombopag atcSuffix "BX05".
- Eltrombopag bioavailability "~52%".
- Eltrombopag c "25".
- Eltrombopag casNumber "496775".
- Eltrombopag chembl "461101".
- Eltrombopag chemspiderid "21106301".
- Eltrombopag eliminationHalfLife "-126000.0".
- Eltrombopag excretion "feces , urine".
- Eltrombopag h "22".
- Eltrombopag inchi "1".
- Eltrombopag inchikey "XDXWLKQMMKQXPV-HPNDGRJYBX".
- Eltrombopag iupacName "3".
- Eltrombopag legalUs "Rx Only".
- Eltrombopag licenceEu "Revolade".
- Eltrombopag licenceUs "Eltrombopag".
- Eltrombopag medlineplus "a609011".
- Eltrombopag metabolism "extensive hepatic".
- Eltrombopag molecularWeight "442.467".
- Eltrombopag n "4".
- Eltrombopag o "4".
- Eltrombopag pregnancyAu "B3".
- Eltrombopag pregnancyUs "C".
- Eltrombopag pubchem "9846180".
- Eltrombopag routesOfAdministration "Oral".
- Eltrombopag smiles "CC1=CC".
- Eltrombopag stdinchi "1".
- Eltrombopag stdinchikey "XDXWLKQMMKQXPV-HPNDGRJYSA-N".
- Eltrombopag tradename "Promacta, Revolade".
- Eltrombopag unii "S56D65XJ9G".
- Eltrombopag verifiedfields "changed".
- Eltrombopag verifiedrevid "461093150".
- Eltrombopag width "270".
- Eltrombopag wikiPageUsesTemplate Template:Antihemorrhagics.
- Eltrombopag wikiPageUsesTemplate Template:CAS.
- Eltrombopag wikiPageUsesTemplate Template:Cascite.
- Eltrombopag wikiPageUsesTemplate Template:Chemspidercite.
- Eltrombopag wikiPageUsesTemplate Template:Drugbankcite.
- Eltrombopag wikiPageUsesTemplate Template:Drugbox.
- Eltrombopag wikiPageUsesTemplate Template:Drugs.com.
- Eltrombopag wikiPageUsesTemplate Template:Ebicite.
- Eltrombopag wikiPageUsesTemplate Template:Fdacite.
- Eltrombopag wikiPageUsesTemplate Template:GlaxoSmithKline.
- Eltrombopag wikiPageUsesTemplate Template:Reflist.
- Eltrombopag wikiPageUsesTemplate Template:Stdinchicite.
- Eltrombopag subject Category:Biphenyls.
- Eltrombopag subject Category:Breakthrough_therapy.
- Eltrombopag subject Category:Carboxylic_acids.
- Eltrombopag subject Category:Drugs_acting_on_the_cardiovascular_system.
- Eltrombopag subject Category:Hydrazines.
- Eltrombopag subject Category:Orphan_drugs.
- Eltrombopag hypernym Medication.
- Eltrombopag type ChemicalSubstance.